Higher Death Rate Among Youth With First Episode Psychosis
BETHESDA, Md -- April 7, 2017 -- Young people experiencing first episode psychosis have a much higher death rate than previously thought, according to a study published online by Schizophrenia Bulletin.
Michael Schoenbaum, PhD, National Institute of Mental Health (NIMH), part of the National Institutes of Health (NIH), Bethesda, Maryland, and colleagues analysed data on approximately 5,000 individuals aged 16 to 30 years with commercial health insurance who had received a new psychosis diagnosis, and followed them for the next 12 months.
The researchers found that the group had a mortality rate at least 24 times greater than the same age group in the general population in the 12 months after the initial psychosis diagnosis.
The findings underscore that young people experiencing psychosis warrant intensive and proactive treatments, services and supports.
The research team used insurance claims data to identify young people aged 16 to 30 years who had been diagnosed with a first episode of psychosis between 2008 and 2009. They used data from the Social Security Administration to identify deaths in this population within 12 months of the initial psychosis diagnosis. Data on cause or manner of death were not available.
The 12-month mortality rate for these young people -- from any cause -- was at least 24 times higher than their peers in the general population. In the general US population, only individuals aged older than 70 years come close to a similar 12-month mortality rate.
“These findings show the importance of tracking mortality in individuals with mental illness,” said Dr. Schoenbaum. “Health systems do this in other areas of medicine, such as cancer and cardiology, but not for mental illness. Of course, we also need to learn how these young people are losing their lives.”
In addition to mortality, the study examined the health care individuals received in the 12 months after the initial psychosis diagnosis. Those data showed that young people with a new psychosis diagnosis had surprisingly low rates of medical oversight and only modest involvement with psychosocial treatment providers. Overall, 61% of them did not receive any antipsychotic medications and 41% did not receive any psychotherapy. Those who died within 12 months of diagnosis received even less outpatient treatment and relied more heavily on hospital and emergency care.
“Other studies have shown that early coordinated treatment for psychosis produces the best results,” said co-author Robert Heinssen, PhD, NIMH. “However, we know that the typical duration of untreated psychosis in the United States is around 17 months. This study reinforces federal and state support for funding evidence-based psychosis treatment programs across the country, and the need for communities to invest in more treatment programs.”
“The future of this research will show us what is happening with young people in this population, and help us tailor interventions to address their risks,” said Dr. Schoenbaum. “In the meantime, this study is a wake-up call telling us that young people experiencing psychosis need intensive, integrated clinical and psychosocial supports.”
SOURCE: National Institutes of Health
DG News lets you be the first to know advances in medical research, results from conferences, and changes in healthcare policy and business.